APAS Contact Plate Application Product Launch
| Stock | CC5.ASX (CC5.ASX) |
|---|---|
| Release Time | 27 Aug 2025, 8:16 a.m. |
| Price Sensitive | Yes |
Clever Culture Systems Launches APAS Contact Plate Application
- Successful validation of AI-analysis module for 55mm contact plates
- Expands total addressable market and boosts recurring revenue potential
- Large-scale 20,000+ plate study confirms APAS performance against manual reads
Clever Culture Systems Ltd (ASX: CC5) has announced the successful validation of its new smaller APAS® contact plate (55mm) analysis module on the APAS® Independence platform. This development unlocks expanded market potential for the APAS® technology within the pharmaceutical manufacturing sector. Key highlights include: the finalization of the APAS® contact plate application making it market-ready, the expansion of the total addressable market and boost to recurring revenue potential per APAS® instrument sale, a large-scale 20,000+ plate study confirming APAS® performance against manual microbiologist reads with a 0% false negative rate, and the commencement of product launch activities expected to unlock sales pipeline opportunities. The addition of the contact plate application to the APAS® Independence now offers a single technology platform capable of covering the vast majority of environmental monitoring tests performed in pharmaceutical manufacturing, further strengthening the competitive differentiation of APAS® Independence. The contact plate analysis module is offered as an additional analysis module on the APAS® Independence platform, creating an increased recurring revenue stream, and upgrade kits are available for existing customers. CCS has an active pipeline of over 40 qualified sales opportunities for the APAS® Independence in the pharmaceutical market, representing an estimated 150+ APAS® instrument sales, including approximately 60-80 opportunities with existing APAS® customers, which are expected to be accelerated by the availability of the contact plate application.
The successful validation of the APAS® contact plate analysis module is expected to further accelerate uptake of the APAS® Independence technology across pharmaceutical manufacturing customers.
The availability of the contact plate application is expected to accelerate traction with existing APAS® customers who are seeking a complete automation solution for the environmental monitoring plate workflow.